Sfoglia per AUTORE
DESHPANDE S
Collezione AOU Città della Salute di Torino
Items : 2
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma. in The New England journal of medicine / N Engl J Med. 2022 Jun 30;386(26):2482-2494. doi: 10.1056/NEJMoa2201817. Epub 2022 Jun 3.
2022
AOU Città della Salute di Torino
AOU Città della Salute di Torino
Wang ML; Jurczak W; Jerkeman M; Trotman J; Zinzani PL; Belada D; Boccomini C; Flinn IW; Giri P; Goy A; Hamlin PA; Hermine O; Hernández-Rivas JÁ; Hong X; Kim SJ; Lewis D; Mishima Y; Özcan M; Perini GF; Pocock C; Song Y; Spurgeon SE; Storring JM; Walewski J; Zhu J; Qin R; Henninger T; Deshpande S; Howes A; et alii...
Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2018 Aug 10;36(23):2405-2412. doi: 10.1200/JCO.2017.76.8853. Epub 2018 May 31.
2018
AOU Città della Salute di Torino
AOU Città della Salute di Torino
Salles G; Cheson BD; Vermeulen J; Balasubramanian S; Schaffer M; Damle RN; Wang SS; Gartenberg GJ; Deshpande S; Caballero D; Morton J; Jurczak W; Radford J; Spencer A; Vitolo U; Martin P; Lill M; Yacoub A; Hou JZ; Hess G; Trotman J; Fowler NH; Schuster SJ; Gopal AK; Gopal AK; Schuster SJ; Fowler NH; Trotman J; Hess G; et alii...